Suanfarma Suanfarma

X

Find the latest Drugs in Development and Pipeline Prospector News of Ingenia Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Ingenia Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
650 East Kendall St. Ipsen Biolabs, 2FL Cambridge, MA 02142
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

By harnessing the immense expertise and resources of both companies, the collaboration aims to accelerate the development of innovative therapeutics for immunological disorders with highly unmet needs.


Lead Product(s): Undisclosed

Therapeutic Area: Immunology Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Large molecule

Recipient: Nona Biosciences

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration October 13, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

IGT-427 is a bispecific antibody that potently blocks VEGF and activates Tie-2. Variants of IGT-427 had long intravitreal half-lives, suggesting potential for a less frequently administered and highly efficacious treatment for diabetic macular edema and wet AMA.


Lead Product(s): IGT-427

Therapeutic Area: Ophthalmology Product Name: IGT-427

Highest Development Status: PreclinicalProduct Type: Large molecule

Partner/Sponsor/Collaborator: Mosaic Biosciences

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 02, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY